Cargando…

Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions

BACKGROUND: Infliximab is a weight-based prescription for multiple autoimmune diseases and is dispensed only in single-use, 100mg vials. We aim to compute the quantity of infliximab waste at our site and in an ideal world where weight-based prescribing practices are followed. We estimate hypothetica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schachne, Jonathan M, Durbin, Laura L, Lacher, Corey R, Sangha, Maheep, Mone, Anjali, Swaminath, Arun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802240/ https://www.ncbi.nlm.nih.gov/pubmed/36777267 http://dx.doi.org/10.1093/crocol/otab071

Ejemplares similares

Review of inflammatory bowel disease and COVID-19
por: Sultan, Keith, et al.
Publicado: (2020)

The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection
por: Okeke, Francis, et al.
Publicado: (2020)

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States
por: Smith, Joshua T, et al.
Publicado: (2021)

Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease
por: Guerra Veloz, María Fernanda, et al.
Publicado: (2018)

Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
por: Minar, Phillip, et al.
Publicado: (2019)

Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction
por: Normatov, Inessa, et al.
Publicado: (2021)

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
por: Timper, Katharina, et al.
Publicado: (2013)

Real-world data on the infliximab biosimilar CT-P13 (Remsima(®)) in inflammatory bowel disease
por: Huguet, Jose María, et al.
Publicado: (2021)

Increased Mortality and Healthcare Costs Upon Hospital Readmissions of Ulcerative Colitis Flares: A Large Population-Based Cohort Study
por: Weissman, Simcha, et al.
Publicado: (2021)

The Ideal Physician
Publicado: (1885)

The Ideal Physician
Publicado: (1885)

The Ideal Physician
Publicado: (1892)

Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
por: Shi, Ji-Hao, et al.
Publicado: (2020)

Fatigue in Inflammatory Bowel Diseases: Etiologies and Management
por: Nocerino, Angelica, et al.
Publicado: (2019)

Identification of chronic wasting disease prions in decaying tongue tissues from exhumed white-tailed deer
por: Soto, Paulina, et al.
Publicado: (2023)

Freeze-Drying of Pharmaceuticals in Vials Nested in a Rack System—Part I: Freezing Behaviour
por: Pisano, Roberto, et al.
Publicado: (2023)

Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study
por: Viola, Anna, et al.
Publicado: (2017)

Adalimumab, Infliximab, and Vedolizumab in Treatment of Ulcerative Colitis: A Long-Term Retrospective Study in a Tertiary Referral Center
por: Gagnon, Ann-Lorie, et al.
Publicado: (2021)

Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue
por: Scheiner, D., et al.
Publicado: (2016)

Joint engineering‐medical school programs prepare physicians for clinical challenges: An observational study
por: Gathman, Tyler J., et al.
Publicado: (2023)

Proactive Drug Monitoring Is Associated With Higher Persistence to Infliximab and Adalimumab Treatment and Lower Healthcare Utilization Compared With Reactive and Clinical Monitoring
por: Syed, Nauroz, et al.
Publicado: (2020)

Clostridium difficile Infection Rates During the Pandemic in New York Capital Area: A Single-Center Study
por: Zouridis, Spyridon, et al.
Publicado: (2023)

Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients
por: Pierik, Marieke J, et al.
Publicado: (2021)

Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19
por: Sultan, Keith, et al.
Publicado: (2021)

A comparative study of freeze-drying heat transfer in polymeric vials and glass vials
por: Sarmadi, Morteza, et al.
Publicado: (2023)

The Freeze-Drying of Pharmaceuticals in Vials Nested in a Rack System—Part II: Primary Drying Behaviour
por: Artusio, Fiora, et al.
Publicado: (2023)

Early Start of Infliximab in Crohn’s Disease Increases Rates of Endoscopic Remission and Decreases Stenosis Formation: Experiences From a Single Center Cohort
por: Schnitzler, Fabian, et al.
Publicado: (2021)

Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study
por: Abushamma, Suha, et al.
Publicado: (2023)

Cannabis Use and Its Association With Thirty- and Ninety-Day Hospital Readmissions for Patients Admitted for an Inflammatory Bowel Disease Exacerbation
por: Oseni, Ellen A., et al.
Publicado: (2023)

Seguridad vial en carreteras /
por: Mendoza Díaz, Alberto
Publicado: (2011)

Gestión de infraestructura vial /
por: Solminihac T., Hernán de
Publicado: (2005)

Glosario de planificación vial
por: Lazo Margáin, Leonardo
Publicado: (1985)

Empty vials make most sound: Empty sterile hyaluronidase vials demand quality check
por: Dogra, Neeti, et al.
Publicado: (2021)

SWEAT ICU—An Observational Study of Physician Workload and the Association of Physician Outcomes in Academic ICUs
por: Agarwal, Ankita, et al.
Publicado: (2022)

The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
por: Donners, Anouk A.M.T., et al.
Publicado: (2023)

Vial-splitting and Repackaging into Aliquot-specific Syringes: A Cost-effective and Waste-decreasing Strategy for Sugammadex
por: Amaya, Sebastian, et al.
Publicado: (2023)

Seguridad vial : del factor humano a las nuevas tecnologías /
Publicado: (1995)

Molded Vial Manufacturing and Its Impact on Heat Transfer during Freeze-Drying: Vial Geometry Considerations
por: Wenzel, Tim, et al.
Publicado: (2021)

Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients
por: Kraja, Bledar, et al.
Publicado: (2017)

Red vial ciudad de Xalapa /
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ukirv6qqlkvfqln6siunh9b3jk